GABAPENTIN
- Product NDC
- 76282-321
- 11-digit product format
- 762820321
- Labeler code
- 76282
- Product ID
- 76282-321_5e0a57d7-9068-43d3-be26-96f646720fde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Exelan Pharmaceuticals, Inc.
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2010-04-26
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GABAPENTIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 310430, 310431, 310432 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76282-321 | GABAPENTIN CAPSULE [EXELAN PHARMACEUTICALS, INC.] | 10 | Current NDC, Legacy NDC, 5 package rows | 20241115_41d1ead3-046e-4abf-ae0a-cb126a1f5848.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 76282-321-01 | 76282032101 | 100 CAPSULE in 1 BOTTLE (76282-321-01) | 100 capsule | 2010-04-26 | 0000-00-00 | No | No | Current |
| 76282-321-05 | 76282032105 | 500 CAPSULE in 1 BOTTLE (76282-321-05) | 500 capsule | 2010-04-26 | 0000-00-00 | No | No | Current |
| 76282-321-18 | 76282032118 | 180 CAPSULE in 1 BOTTLE (76282-321-18) | 180 capsule | 2013-03-20 | 0000-00-00 | No | No | Current |
| 76282-321-27 | 76282032127 | 270 CAPSULE in 1 BOTTLE (76282-321-27) | 270 capsule | 2013-03-20 | 0000-00-00 | No | No | Current |
| 76282-321-90 | 76282032190 | 90 CAPSULE in 1 BOTTLE (76282-321-90) | 90 capsule | 2013-03-20 | 0000-00-00 | No | No | Current |